Biologics Regulatory Baxter Announces U.S. FDA Clearance of Altapore Shape Bioactive Bone Graft for Use in Surgery byJosh SandbergJuly 9, 2020
Biologics Extremities Spine Bioventus Receives FDA Clearance of Strip Format of its SIGNAFUSE® Bioactive Bone Graft byJosh SandbergJune 25, 2020
Biologics Biogennix Remains Operational as it Prepares for Post-Coronavirus Surgical Demand byJosh SandbergApril 14, 2020
Biologics BBS-Bioactive Bone Substitutes Plc: We are pleased to announce that the clinical result of ARTEBONE® is positive yielding an outcome similar to patient’s own bone graft byJosh SandbergFebruary 19, 2020
Hospitals UK based medical device company announces two new patents granted by the US Patent and Trademark Office byJosh SandbergJanuary 26, 2017
Extremities AxoGen, Inc.’s Avance® Nerve Graft Data to be Presented at 2016 Federation of European Societies for Surgery of the Hand International Congress byJosh SandbergJune 21, 2016
Spine Medtronic Responds to Star Tribune Article Regarding INFUSE Bone Graft byJosh SandbergApril 11, 2016
Extremities Grafix Demonstrates Positive Clinical Outcomes in Chronic Complex Wounds with Exposed Tendon and Bone byJosh SandbergMarch 7, 2016
